← Home / IONIS PHARMACEUTICALS INC (IONS)
Stock Analysis

IONIS PHARMACEUTICALS INC (IONS)

IONS
IONS · Healthcare • Biotechnology
63.36 -0.29%
Track IONS in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IONS price is:
52W Range Position
48%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-08-26 23:22 UTC
WOI Investment Thesis
Vulnerable
Current market structure would strengthen above 64.72. Holding above 60.49 preserves the current price structure.
⚖️
✓
Fundamentals
Weak / Negative / Pressured / Manageable
✓
Price Structure
Vulnerable
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
60.49
↗
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
64.72
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
29
●
Financial Results
HIGH
IONS reports financial results
On July 29, 2026, Ionis Pharmaceuticals, Inc.
8-K Filing • SEC EDGAR
APR
29
●
Financial Results
HIGH
Ionis reports first quarter 2026 financial results and highlights progress on key programs
(Nasdaq: IONS) (the “Company”) today reported financial results and provided key updates for the first quarter ended March 31, 2026.
8-K Filing • SEC EDGAR
What's Driving IONS?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Revenue growth is weak. Profitability is negative. Cash generation is pressured. Balance-sheet quality is manageable.
⚠️ Key risk remains
losing 60.49 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
60.7
◎
How to read this setup
The nearest decision zone is framed by support around 60.49 and resistance near 64.72. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
IONS — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-25
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$10.3B
Company size
EV
$10.4B
Debt-adjusted value
P/S
11.8
Premium
P/B
23.4
Very high
EV/Sales
11.9
Premium
EV/EBIT
-31.2
Not meaningful
P/FCF
-29.7
Not meaningful
FCF Yield
-3.36%
Cash return
Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Manageable
💵 Revenue
267.95M
↘ Weak
📈 Net Income
-114.65M
↘ Negative
🧮 EPS (Basic)
-0.69
↘ Negative
IONIS PHARMACEUTICALS INC
Healthcare • Biotechnology
You Might Also Like